| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |